SIMILAR PATTERNS OF AMINO ACIDS FOR 3G4L_A_ROFA901

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1soj CGMP-INHIBITED
3',5'-CYCLIC
PHOSPHODIESTERASE B


(Homo sapiens)
PF00233
(PDEase_I)
5 TYR A 736
HIS A 737
PRO A 941
SER A 990
PHE A 991
IBM  A2111 (-4.5A)
IBM  A2111 ( 4.8A)
None
None
IBM  A2111 (-3.6A)
1.25A 3g4lA-1sojA:
42.0
3g4lA-1sojA:
32.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1soj CGMP-INHIBITED
3',5'-CYCLIC
PHOSPHODIESTERASE B


(Homo sapiens)
PF00233
(PDEase_I)
7 TYR A 736
HIS A 737
PRO A 941
TRP A 951
THR A 952
ILE A 955
PHE A 991
IBM  A2111 (-4.5A)
IBM  A2111 ( 4.8A)
None
None
IBM  A2111 ( 4.8A)
IBM  A2111 (-4.2A)
IBM  A2111 (-3.6A)
0.53A 3g4lA-1sojA:
42.0
3g4lA-1sojA:
32.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xkh FERRIPYOVERDINE
RECEPTOR


(Pseudomonas
aeruginosa)
PF00593
(TonB_dep_Rec)
PF07715
(Plug)
5 HIS A 324
ASN A 384
PRO A 367
SER A 440
PHE A 503
None
1.33A 3g4lA-1xkhA:
undetectable
3g4lA-1xkhA:
19.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1zkl HIGH-AFFINITY
CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 7A


(Homo sapiens)
PF00233
(PDEase_I)
6 TYR A 211
HIS A 212
ASN A 365
PRO A 366
TRP A 376
PHE A 416
IBM  A 503 (-4.6A)
None
IBM  A 503 ( 4.7A)
None
None
IBM  A 503 (-3.4A)
0.42A 3g4lA-1zklA:
45.4
3g4lA-1zklA:
33.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1znp HYPOTHETICAL PROTEIN
ATU3615


(Agrobacterium
fabrum)
PF06172
(Cupin_5)
5 TYR A  25
HIS A  19
THR A  28
ILE A  43
SER A  40
None
1.31A 3g4lA-1znpA:
undetectable
3g4lA-1znpA:
16.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2qyk CYCLIC AMP-SPECIFIC
PHOSPHODIESTERASE
HSPDE4A10


(Homo sapiens)
PF00233
(PDEase_I)
12 TYR A 371
HIS A 372
MET A 485
ASN A 533
PRO A 534
TYR A 541
TRP A 544
THR A 545
ILE A 548
MET A 569
SER A 580
PHE A 584
NPV  A   3 (-4.4A)
NPV  A   3 (-4.6A)
None
NPV  A   3 (-4.4A)
None
None
None
NPV  A   3 ( 4.7A)
NPV  A   3 (-3.8A)
NPV  A   3 (-3.1A)
NPV  A   3 (-4.5A)
NPV  A   3 (-3.3A)
0.49A 3g4lA-2qykA:
51.8
3g4lA-2qykA:
85.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2qym PHOSPHODIESTERASE 4C

(Homo sapiens)
PF00233
(PDEase_I)
9 TYR A 281
HIS A 282
MET A 395
ASN A 443
PRO A 444
TRP A 454
THR A 455
ILE A 458
PHE A 494
None
0.59A 3g4lA-2qymA:
43.1
3g4lA-2qymA:
83.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2qym PHOSPHODIESTERASE 4C

(Homo sapiens)
PF00233
(PDEase_I)
9 TYR A 281
HIS A 282
MET A 395
ASN A 443
PRO A 444
TYR A 451
TRP A 454
THR A 455
PHE A 494
None
0.60A 3g4lA-2qymA:
43.1
3g4lA-2qymA:
83.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2r8q CLASS I
PHOSPHODIESTERASE
PDEB1


(Leishmania
major)
PF00233
(PDEase_I)
6 TYR A 680
HIS A 681
MET A 797
ASN A 838
TRP A 849
PHE A 890
IBM  A   3 ( 4.7A)
IBM  A   3 ( 4.8A)
None
IBM  A   3 (-4.5A)
None
IBM  A   3 (-3.6A)
0.40A 3g4lA-2r8qA:
38.8
3g4lA-2r8qA:
29.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ecn HIGH AFFINITY
CAMP-SPECIFIC AND
IBMX-INSENSITIVE
3',5'-CYCLIC
PHOSPHODIESTERASE 8A


(Homo sapiens)
PF00233
(PDEase_I)
5 MET A 670
ASN A 729
PRO A 730
SER A 780
PHE A 781
IBM  A   3 (-4.5A)
None
None
None
IBM  A   3 (-3.5A)
1.01A 3g4lA-3ecnA:
44.8
3g4lA-3ecnA:
32.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ecn HIGH AFFINITY
CAMP-SPECIFIC AND
IBMX-INSENSITIVE
3',5'-CYCLIC
PHOSPHODIESTERASE 8A


(Homo sapiens)
PF00233
(PDEase_I)
9 TYR A 555
HIS A 556
MET A 670
ASN A 729
PRO A 730
TRP A 740
ILE A 744
SER A 777
PHE A 781
None
None
IBM  A   3 (-4.5A)
None
None
None
IBM  A   3 (-4.3A)
None
IBM  A   3 (-3.5A)
0.43A 3g4lA-3ecnA:
44.8
3g4lA-3ecnA:
32.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3g4g CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
5 HIS A 326
MET A 439
MET A 523
SER A 534
PHE A 538
D71  A 901 (-4.5A)
D71  A 901 ( 4.0A)
D71  A 901 ( 4.0A)
D71  A 901 (-3.4A)
D71  A 901 (-3.9A)
1.03A 3g4lA-3g4gA:
52.5
3g4lA-3g4gA:
74.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3g4g CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
11 TYR A 325
HIS A 326
MET A 439
ASN A 487
PRO A 488
TYR A 495
TRP A 498
THR A 499
ILE A 502
MET A 523
PHE A 538
None
D71  A 901 (-4.5A)
D71  A 901 ( 4.0A)
D71  A 901 (-4.5A)
None
None
None
D71  A 901 (-3.6A)
D71  A 901 (-4.1A)
D71  A 901 ( 4.0A)
D71  A 901 (-3.9A)
0.61A 3g4lA-3g4gA:
52.5
3g4lA-3g4gA:
74.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o57 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
PF00233
(PDEase_I)
12 TYR A 233
HIS A 234
MET A 347
ASN A 395
PRO A 396
TYR A 403
TRP A 406
THR A 407
ILE A 410
MET A 431
SER A 442
PHE A 446
None
None
ZG2  A 506 (-3.9A)
ZG2  A 506 (-4.3A)
ZG2  A 506 ( 4.5A)
None
None
ZG2  A 506 (-4.3A)
ZG2  A 506 (-4.4A)
ZG2  A 506 (-3.4A)
None
ZG2  A 506 (-3.6A)
0.53A 3g4lA-3o57A:
51.6
3g4lA-3o57A:
80.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qi3 HIGH AFFINITY
CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 9A


(Homo sapiens)
PF00233
(PDEase_I)
5 HIS A 252
MET A 365
ASN A 405
TRP A 416
PHE A 456
PDB  A 600 (-4.6A)
PDB  A 600 ( 4.7A)
PDB  A 600 (-4.4A)
None
PDB  A 600 (-3.5A)
0.58A 3g4lA-3qi3A:
41.8
3g4lA-3qi3A:
24.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rko NADH-QUINONE
OXIDOREDUCTASE
SUBUNIT L


(Escherichia
coli)
no annotation 5 MET L 432
TYR L 102
ILE L 353
MET L 243
SER L 250
None
1.37A 3g4lA-3rkoL:
undetectable
3g4lA-3rkoL:
21.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
10 TYR A 159
HIS A 160
ASN A 321
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
MET A 357
SER A 368
TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
0.52A 3g4lA-3sl5A:
53.4
3g4lA-3sl5A:
98.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
11 TYR A 159
HIS A 160
MET A 273
ASN A 321
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
SER A 368
PHE A 372
TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
ASN  A 321 (-0.6A)
PRO  A 322 (-1.1A)
TYR  A 329 (-1.3A)
TRP  A 332 ( 0.5A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
SER  A 368 (-0.0A)
PHE  A 372 (-1.3A)
0.44A 3g4lA-3sl5A:
53.4
3g4lA-3sl5A:
98.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3v94 CYCLIC NUCLEOTIDE
SPECIFIC
PHOSPHODIESTERASE


(Trypanosoma
cruzi)
PF00233
(PDEase_I)
6 TYR A 367
HIS A 368
MET A 482
TRP A 535
ILE A 538
PHE A 573
WYQ  A 701 (-4.5A)
None
WYQ  A 701 (-4.5A)
None
WYQ  A 701 ( 4.1A)
WYQ  A 701 (-3.4A)
0.75A 3g4lA-3v94A:
39.7
3g4lA-3v94A:
30.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4i15 CLASS 1
PHOSPHODIESTERASE
PDEB1


(Trypanosoma
brucei)
PF00233
(PDEase_I)
6 TYR A 668
HIS A 669
MET A 785
ASN A 825
TRP A 836
PHE A 877
None
0.44A 3g4lA-4i15A:
38.2
3g4lA-4i15A:
32.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4udj UHGB_MP

(uncultured
organism)
PF04041
(Glyco_hydro_130)
5 TYR A 300
ASN A  28
PRO A  29
THR A 307
SER A  41
None
None
PGE  A 608 (-3.8A)
None
K  A 606 (-2.6A)
1.27A 3g4lA-4udjA:
undetectable
3g4lA-4udjA:
19.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wzi CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
PF00233
(PDEase_I)
11 TYR A 405
HIS A 406
MET A 519
ASN A 567
PRO A 568
TRP A 578
THR A 579
ILE A 582
MET A 603
SER A 614
PHE A 618
None
MG  A 804 ( 4.9A)
None
None
None
None
None
None
None
None
None
0.74A 3g4lA-4wziA:
52.2
3g4lA-4wziA:
47.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wzi CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
PF00233
(PDEase_I)
11 TYR A 405
HIS A 406
MET A 519
ASN A 567
PRO A 568
TYR A 575
TRP A 578
THR A 579
MET A 603
SER A 614
PHE A 618
None
MG  A 804 ( 4.9A)
None
None
None
None
None
None
None
None
None
0.60A 3g4lA-4wziA:
52.2
3g4lA-4wziA:
47.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z81 EGF FAMILY
DOMAIN-CONTAINING
PROTEIN


(Toxoplasma
gondii)
PF02430
(AMA-1)
PF07974
(EGF_2)
5 ASN A 171
THR A 167
MET A 373
SER A 164
PHE A 156
None
1.47A 3g4lA-4z81A:
undetectable
3g4lA-4z81A:
20.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b25 CALCIUM/CALMODULIN-D
EPENDENT
3',5'-CYCLIC
NUCLEOTIDE
PHOSPHODIESTERASE 1B


(Homo sapiens)
PF00233
(PDEase_I)
8 TYR A 222
HIS A 223
MET A 336
PRO A 374
TRP A 384
THR A 385
SER A 420
PHE A 424
None
4QJ  A 603 ( 4.9A)
4QJ  A 603 ( 3.9A)
None
None
None
4QJ  A 603 (-4.7A)
4QJ  A 603 (-3.5A)
0.43A 3g4lA-5b25A:
43.8
3g4lA-5b25A:
37.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5h2r PHOSPHODIESTERASE

(Trypanosoma
brucei)
no annotation 5 MET A 785
ASN A 826
TRP A 837
MET A 862
PHE A 878
LLN  A1003 (-4.0A)
LLN  A1003 (-4.4A)
None
LLN  A1003 (-3.5A)
LLN  A1003 (-3.8A)
0.98A 3g4lA-5h2rA:
38.8
3g4lA-5h2rA:
31.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5h2r PHOSPHODIESTERASE

(Trypanosoma
brucei)
no annotation 6 TYR A 668
HIS A 669
MET A 785
ASN A 826
TRP A 837
PHE A 878
LLN  A1003 ( 4.8A)
None
LLN  A1003 (-4.0A)
LLN  A1003 (-4.4A)
None
LLN  A1003 (-3.8A)
0.34A 3g4lA-5h2rA:
38.8
3g4lA-5h2rA:
31.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ohj CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
no annotation 9 TYR A 405
ASN A 567
PRO A 568
TYR A 575
TRP A 578
THR A 579
ILE A 582
MET A 603
PHE A 618
None
9VE  A 801 (-4.1A)
9VE  A 801 (-3.9A)
9VE  A 801 (-4.6A)
None
9VE  A 801 (-4.1A)
9VE  A 801 (-4.1A)
9VE  A 801 (-3.6A)
9VE  A 801 (-3.9A)
0.68A 3g4lA-5ohjA:
51.7
3g4lA-5ohjA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ohj CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
no annotation 11 TYR A 405
HIS A 406
MET A 519
ASN A 567
PRO A 568
TYR A 575
TRP A 578
THR A 579
ILE A 582
SER A 614
PHE A 618
None
None
9VE  A 801 (-3.8A)
9VE  A 801 (-4.1A)
9VE  A 801 (-3.9A)
9VE  A 801 (-4.6A)
None
9VE  A 801 (-4.1A)
9VE  A 801 (-4.1A)
9VE  A 801 (-4.7A)
9VE  A 801 (-3.9A)
0.27A 3g4lA-5ohjA:
51.7
3g4lA-5ohjA:
undetectable
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vyd PHOSPHODIESTERASE

(Salpingoeca
rosetta)
no annotation 5 HIS A  83
MET A 195
ASN A 239
PRO A 240
PHE A 291
None
0.71A 3g4lA-5vydA:
39.6
3g4lA-5vydA:
30.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wh6 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
no annotation 11 TYR A 159
HIS A 160
MET A 273
ASN A 321
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
MET A 357
PHE A 372
AKJ  A 601 ( 4.7A)
None
AKJ  A 601 ( 3.9A)
AKJ  A 601 (-4.3A)
AKJ  A 601 (-3.9A)
AKJ  A 601 (-4.8A)
None
AKJ  A 601 (-4.1A)
AKJ  A 601 (-3.8A)
AKJ  A 601 (-3.4A)
AKJ  A 601 (-4.1A)
0.42A 3g4lA-5wh6A:
54.2
3g4lA-5wh6A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wh6 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
no annotation 9 TYR A 159
HIS A 160
PRO A 322
TYR A 329
TRP A 332
THR A 333
ILE A 336
MET A 357
SER A 368
AKJ  A 601 ( 4.7A)
None
AKJ  A 601 (-3.9A)
AKJ  A 601 (-4.8A)
None
AKJ  A 601 (-4.1A)
AKJ  A 601 (-3.8A)
AKJ  A 601 (-3.4A)
AKJ  A 601 (-2.5A)
0.66A 3g4lA-5wh6A:
54.2
3g4lA-5wh6A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xjh POLY(ETHYLENE
TEREPHTHALATE)
HYDROLASE


(Ideonella
sakaiensis)
no annotation 5 PRO A  99
TYR A  69
THR A 110
ILE A  83
SER A  92
None
1.08A 3g4lA-5xjhA:
undetectable
3g4lA-5xjhA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xjh POLY(ETHYLENE
TEREPHTHALATE)
HYDROLASE


(Ideonella
sakaiensis)
no annotation 5 PRO A  99
TYR A  69
THR A 110
ILE A  83
SER A  93
None
1.30A 3g4lA-5xjhA:
undetectable
3g4lA-5xjhA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yfb DIPEPTIDYL PEPTIDASE
3


(Armillaria
tabescens)
no annotation 5 TYR A 276
HIS A 288
ILE A 307
SER A 375
PHE A 326
None
1.11A 3g4lA-5yfbA:
undetectable
3g4lA-5yfbA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ane POLY(ETHYLENE
TEREPHTHALATE)
HYDROLASE


(Ideonella
sakaiensis)
no annotation 5 PRO A  72
TYR A  42
THR A  83
ILE A  56
SER A  65
None
1.06A 3g4lA-6aneA:
undetectable
3g4lA-6aneA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ane POLY(ETHYLENE
TEREPHTHALATE)
HYDROLASE


(Ideonella
sakaiensis)
no annotation 5 PRO A  72
TYR A  42
THR A  83
ILE A  56
SER A  66
None
1.31A 3g4lA-6aneA:
undetectable
3g4lA-6aneA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dcq PYK2-ASSOCIATED
PROTEIN BETA


(Mus musculus)
PF01412
(ArfGap)
PF12796
(Ank_2)
3 ASP A 307
LEU A 309
GLN A 437
None
0.71A 3g4lA-1dcqA:
undetectable
3g4lA-1dcqA:
22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1eak 72 KDA TYPE IV
COLLAGENASE


(Homo sapiens)
PF00040
(fn2)
PF00413
(Peptidase_M10)
PF01471
(PG_binding_1)
3 ASP A 249
LEU A 257
GLN A 219
None
0.82A 3g4lA-1eakA:
undetectable
3g4lA-1eakA:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ezv UBIQUINOL-CYTOCHROME
C REDUCTASE COMPLEX
CORE PROTEIN I


(Saccharomyces
cerevisiae)
PF00675
(Peptidase_M16)
PF05193
(Peptidase_M16_C)
3 ASP A 191
LEU A 192
GLN A 101
None
0.74A 3g4lA-1ezvA:
undetectable
3g4lA-1ezvA:
21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1g8k ARSENITE OXIDASE
ARSENITE OXIDASE


(Alcaligenes
faecalis;
Alcaligenes
faecalis)
PF00384
(Molybdopterin)
PF01568
(Molydop_binding)
PF00355
(Rieske)
3 ASP A   5
LEU B 124
GLN A  57
None
0.70A 3g4lA-1g8kA:
undetectable
3g4lA-1g8kA:
18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gl2 SYNTAXIN 7
VESICLE TRANSPORT
V-SNARE PROTEIN
VTI1-LIKE 1


(Mus musculus;
Mus musculus)
PF05739
(SNARE)
PF12352
(V-SNARE_C)
3 ASP B 191
LEU B 192
GLN C 170
None
0.73A 3g4lA-1gl2B:
undetectable
3g4lA-1gl2B:
11.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ii0 ARSENICAL
PUMP-DRIVING ATPASE


(Escherichia
coli)
PF02374
(ArsA_ATPase)
3 ASP A 417
LEU A 418
GLN A 430
None
0.69A 3g4lA-1ii0A:
undetectable
3g4lA-1ii0A:
22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jog HYPOTHETICAL PROTEIN
HI0074


(Haemophilus
influenzae)
PF08780
(NTase_sub_bind)
3 ASP A  12
LEU A  11
GLN A  64
None
0.83A 3g4lA-1jogA:
undetectable
3g4lA-1jogA:
18.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1moe ANTI-CEA MAB T84.66

(Mus musculus)
PF07686
(V-set)
3 ASP A  86
LEU A 108
GLN A   6
None
0.80A 3g4lA-1moeA:
undetectable
3g4lA-1moeA:
19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qfx PROTEIN (PH 2.5 ACID
PHOSPHATASE)


(Aspergillus
niger)
PF00328
(His_Phos_2)
3 ASP A 191
LEU A 432
GLN A 304
None
NAG  A 596 (-4.7A)
GOL  A 703 (-4.0A)
0.62A 3g4lA-1qfxA:
undetectable
3g4lA-1qfxA:
21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qgr PROTEIN (IMPORTIN
BETA SUBUNIT)


(Homo sapiens)
PF03810
(IBN_N)
PF13513
(HEAT_EZ)
3 ASP A 579
LEU A 583
GLN A 589
None
0.78A 3g4lA-1qgrA:
undetectable
3g4lA-1qgrA:
19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qnz 0.5B ANTIBODY (LIGHT
CHAIN)


(Mus musculus)
PF07686
(V-set)
3 ASP L  86
LEU L 108
GLN L   6
None
0.66A 3g4lA-1qnzL:
undetectable
3g4lA-1qnzL:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qqf PROTEIN (COMPLEMENT
C3DG)


(Rattus
norvegicus)
PF07678
(A2M_comp)
PF10569
(Thiol-ester_cl)
3 ASP A1140
LEU A1143
GLN A1127
None
0.77A 3g4lA-1qqfA:
undetectable
3g4lA-1qqfA:
22.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tzs CATHEPSIN E

(Homo sapiens)
PF00026
(Asp)
3 ASP A 290
LEU A 288
GLN A 245
None
0.67A 3g4lA-1tzsA:
undetectable
3g4lA-1tzsA:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uio ADENOSINE DEAMINASE

(Mus musculus)
PF00962
(A_deaminase)
3 ASP A 128
LEU A 132
GLN A 138
None
0.80A 3g4lA-1uioA:
undetectable
3g4lA-1uioA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1x9s DNA POLYMERASE

(Escherichia
virus T7)
PF00476
(DNA_pol_A)
3 ASP A  65
LEU A  69
GLN A  76
MG  A3001 ( 4.0A)
None
None
0.81A 3g4lA-1x9sA:
undetectable
3g4lA-1x9sA:
19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a0l 33H1 FV FRAGMENT

(Mus musculus)
PF07686
(V-set)
3 ASP C  83
LEU C 104
GLN C   6
None
0.82A 3g4lA-2a0lC:
undetectable
3g4lA-2a0lC:
14.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bi0 HYPOTHETICAL PROTEIN
RV0216


(Mycobacterium
tuberculosis)
no annotation 3 ASP A 329
LEU A 328
GLN A 260
None
0.80A 3g4lA-2bi0A:
undetectable
3g4lA-2bi0A:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c27 MYCOTHIOL SYNTHASE

(Mycobacterium
tuberculosis)
PF00583
(Acetyltransf_1)
3 ASP A 163
LEU A 167
GLN A 180
None
0.72A 3g4lA-2c27A:
undetectable
3g4lA-2c27A:
23.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2coc FYVE, RHOGEF AND PH
DOMAIN CONTAINING
PROTEIN 3


(Homo sapiens)
no annotation 3 ASP A  46
LEU A  49
GLN A  82
None
0.76A 3g4lA-2cocA:
undetectable
3g4lA-2cocA:
15.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hg4 6-DEOXYERYTHRONOLIDE
B SYNTHASE


(Saccharopolyspora
erythraea)
PF00109
(ketoacyl-synt)
PF00698
(Acyl_transf_1)
PF02801
(Ketoacyl-synt_C)
PF08990
(Docking)
PF16197
(KAsynt_C_assoc)
3 ASP A 722
LEU A 721
GLN A 748
None
0.77A 3g4lA-2hg4A:
undetectable
3g4lA-2hg4A:
16.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i3o GAMMA-GLUTAMYLTRANSF
ERASE RELATED
PROTEIN


(Thermoplasma
acidophilum)
PF01019
(G_glu_transpept)
3 ASP A 330
LEU A  54
GLN A 490
None
0.72A 3g4lA-2i3oA:
undetectable
3g4lA-2i3oA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2inf UROPORPHYRINOGEN
DECARBOXYLASE


(Bacillus
subtilis)
PF01208
(URO-D)
3 ASP A 266
LEU A 265
GLN A 309
None
0.83A 3g4lA-2infA:
undetectable
3g4lA-2infA:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iya OLEANDOMYCIN
GLYCOSYLTRANSFERASE


(Streptomyces
antibioticus)
PF00201
(UDPGT)
3 ASP A 317
LEU A 316
GLN A  34
None
0.63A 3g4lA-2iyaA:
undetectable
3g4lA-2iyaA:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jft SER-THR PHOSPHATASE
MSPP


(Mycolicibacterium
smegmatis)
PF13672
(PP2C_2)
3 ASP A  27
LEU A  30
GLN A 101
None
0.68A 3g4lA-2jftA:
undetectable
3g4lA-2jftA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jg2 SERINE
PALMITOYLTRANSFERASE


(Sphingomonas
paucimobilis)
PF00155
(Aminotran_1_2)
3 ASP A 155
LEU A 201
GLN A 250
None
0.77A 3g4lA-2jg2A:
undetectable
3g4lA-2jg2A:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2m7a UNCHARACTERIZED
PROTEIN


(Escherichia
coli)
no annotation 3 ASP A  42
LEU A  30
GLN A  18
None
0.74A 3g4lA-2m7aA:
undetectable
3g4lA-2m7aA:
14.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oew PROGRAMMED CELL
DEATH 6-INTERACTING
PROTEIN


(Homo sapiens)
PF03097
(BRO1)
3 ASP A  59
LEU A  58
GLN A   8
None
0.81A 3g4lA-2oewA:
undetectable
3g4lA-2oewA:
21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pff FATTY ACID SYNTHASE
SUBUNIT ALPHA


(Saccharomyces
cerevisiae)
PF00106
(adh_short)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
3 ASP A 925
LEU A 926
GLN A 898
None
0.84A 3g4lA-2pffA:
undetectable
3g4lA-2pffA:
11.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pk2 CYCLIN-T1, PROTEIN
TAT


(Homo sapiens;
Equine
infectious
anemia virus)
PF00134
(Cyclin_N)
3 ASP A  32
LEU A  35
GLN A 190
ASP  A  32 ( 0.6A)
LEU  A  35 ( 0.6A)
GLN  A 190 ( 0.6A)
0.59A 3g4lA-2pk2A:
undetectable
3g4lA-2pk2A:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qr6 IMP
DEHYDROGENASE/GMP
REDUCTASE


(Corynebacterium
glutamicum)
PF00478
(IMPDH)
3 ASP A 252
LEU A 251
GLN A 367
None
0.80A 3g4lA-2qr6A:
undetectable
3g4lA-2qr6A:
19.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2qyk CYCLIC AMP-SPECIFIC
PHOSPHODIESTERASE
HSPDE4A10


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 530
LEU A 531
GLN A 581
ZN  A   1 (-2.5A)
None
NPV  A   3 (-3.1A)
0.35A 3g4lA-2qykA:
51.8
3g4lA-2qykA:
85.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2qym PHOSPHODIESTERASE 4C

(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 220
LEU A 226
GLN A 453
None
0.79A 3g4lA-2qymA:
43.1
3g4lA-2qymA:
83.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2uv8 FATTY ACID SYNTHASE
SUBUNIT BETA (FAS1)


(Saccharomyces
cerevisiae)
PF00698
(Acyl_transf_1)
PF01575
(MaoC_dehydratas)
PF08354
(DUF1729)
PF13452
(MaoC_dehydrat_N)
PF16073
(SAT)
3 ASP G1791
LEU G1792
GLN G1659
None
0.82A 3g4lA-2uv8G:
undetectable
3g4lA-2uv8G:
10.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2woc ADP-RIBOSYL-[DINITRO
GEN REDUCTASE]
GLYCOHYDROLASE


(Rhodospirillum
rubrum)
PF03747
(ADP_ribosyl_GH)
3 ASP A  21
LEU A  17
GLN A 283
None
0.63A 3g4lA-2wocA:
undetectable
3g4lA-2wocA:
18.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wrg HEMAGGLUTININ HA2
CHAIN


(Influenza A
virus)
PF00509
(Hemagglutinin)
3 ASP I 586
LEU I 589
GLN I 562
None
0.83A 3g4lA-2wrgI:
undetectable
3g4lA-2wrgI:
19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xn1 ALPHA-GALACTOSIDASE

(Lactobacillus
acidophilus)
PF02065
(Melibiase)
PF16874
(Glyco_hydro_36C)
PF16875
(Glyco_hydro_36N)
3 ASP A  56
LEU A  55
GLN A 272
None
0.83A 3g4lA-2xn1A:
undetectable
3g4lA-2xn1A:
19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xr1 CLEAVAGE AND
POLYADENYLATION
SPECIFICITY FACTOR
100 KD SUBUNIT


(Methanosarcina
mazei)
PF07521
(RMMBL)
PF07650
(KH_2)
PF10996
(Beta-Casp)
PF16661
(Lactamase_B_6)
PF17214
(KH_7)
3 ASP A 279
LEU A 275
GLN A 422
None
0.74A 3g4lA-2xr1A:
undetectable
3g4lA-2xr1A:
20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xub DNA-DIRECTED RNA
POLYMERASE III
SUBUNIT RPC3


(Homo sapiens)
PF05645
(RNA_pol_Rpc82)
PF08221
(HTH_9)
3 ASP A 318
LEU A 320
GLN A 371
None
0.79A 3g4lA-2xubA:
undetectable
3g4lA-2xubA:
21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ycb CLEAVAGE AND
POLYADENYLATION
SPECIFICITY FACTOR


(Methanothermobacter
thermautotrophicus)
PF07521
(RMMBL)
PF10996
(Beta-Casp)
PF16661
(Lactamase_B_6)
PF17214
(KH_7)
3 ASP A 279
LEU A 275
GLN A 422
None
0.79A 3g4lA-2ycbA:
undetectable
3g4lA-2ycbA:
20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zqq METHYLGLUTACONYL-COA
HYDRATASE


(Homo sapiens)
PF00378
(ECH_1)
3 ASP A 273
LEU A 274
GLN A 281
None
0.80A 3g4lA-2zqqA:
undetectable
3g4lA-2zqqA:
24.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b2r CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 764
LEU A 765
GLN A 775
None
VDN  A   1 ( 4.7A)
VDN  A   1 ( 4.4A)
0.68A 3g4lA-3b2rA:
31.3
3g4lA-3b2rA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b2r CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 764
LEU A 765
GLN A 817
None
VDN  A   1 ( 4.7A)
VDN  A   1 (-3.0A)
0.50A 3g4lA-3b2rA:
31.3
3g4lA-3b2rA:
27.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3beo UDP-N-ACETYLGLUCOSAM
INE 2-EPIMERASE


(Bacillus
anthracis)
PF02350
(Epimerase_2)
3 ASP A  49
LEU A  48
GLN A  70
None
None
UD1  A 372 (-3.7A)
0.73A 3g4lA-3beoA:
undetectable
3g4lA-3beoA:
23.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bga BETA-GALACTOSIDASE

(Bacteroides
thetaiotaomicron)
PF00703
(Glyco_hydro_2)
PF02836
(Glyco_hydro_2_C)
PF02837
(Glyco_hydro_2_N)
PF02929
(Bgal_small_N)
PF16353
(DUF4981)
3 ASP A 452
LEU A 449
GLN A 189
None
0.78A 3g4lA-3bgaA:
undetectable
3g4lA-3bgaA:
17.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bjc CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 764
LEU A 765
GLN A 775
ZN  A 876 (-2.5A)
WAN  A 901 ( 4.7A)
WAN  A 901 ( 4.6A)
0.61A 3g4lA-3bjcA:
34.1
3g4lA-3bjcA:
19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bjc CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 764
LEU A 765
GLN A 817
ZN  A 876 (-2.5A)
WAN  A 901 ( 4.7A)
WAN  A 901 (-3.1A)
0.48A 3g4lA-3bjcA:
34.1
3g4lA-3bjcA:
19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ciy TOLL-LIKE RECEPTOR 3

(Mus musculus)
PF00560
(LRR_1)
PF13855
(LRR_8)
3 ASP A 203
LEU A 177
GLN A 107
None
0.79A 3g4lA-3ciyA:
undetectable
3g4lA-3ciyA:
20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d3a BETA-GALACTOSIDASE

(Bacteroides
thetaiotaomicron)
PF01301
(Glyco_hydro_35)
3 ASP A 462
LEU A 464
GLN A 400
None
0.83A 3g4lA-3d3aA:
undetectable
3g4lA-3d3aA:
21.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dec BETA-GALACTOSIDASE

(Bacteroides
thetaiotaomicron)
PF00703
(Glyco_hydro_2)
PF02836
(Glyco_hydro_2_C)
PF02837
(Glyco_hydro_2_N)
PF02929
(Bgal_small_N)
PF16353
(DUF4981)
3 ASP A 428
LEU A 425
GLN A 165
None
0.77A 3g4lA-3decA:
undetectable
3g4lA-3decA:
17.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dwm 9.5 KDA CULTURE
FILTRATE ANTIGEN
CFP10A


(Mycobacterium
tuberculosis)
PF02597
(ThiS)
3 ASP A  34
LEU A  35
GLN A  18
None
0.66A 3g4lA-3dwmA:
undetectable
3g4lA-3dwmA:
16.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e02 UNCHARACTERIZED
PROTEIN DUF849


(Paraburkholderia
xenovorans)
PF05853
(BKACE)
3 ASP A  63
LEU A  66
GLN A  73
None
0.76A 3g4lA-3e02A:
undetectable
3g4lA-3e02A:
20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f1i HEPATOCYTE GROWTH
FACTOR-REGULATED
TYROSINE KINASE
SUBSTRATE


(Homo sapiens)
PF12210
(Hrs_helical)
3 ASP H 461
LEU H 465
GLN H 471
None
0.67A 3g4lA-3f1iH:
undetectable
3g4lA-3f1iH:
15.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3g4g CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 484
LEU A 485
GLN A 535
ZN  A 801 (-2.6A)
None
D71  A 901 (-3.1A)
0.29A 3g4lA-3g4gA:
52.5
3g4lA-3g4gA:
74.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g6i PUTATIVE OUTER
MEMBRANE PROTEIN,
PART OF CARBOHYDRATE
BINDING COMPLEX


(Bacteroides
thetaiotaomicron)
PF12875
(DUF3826)
3 ASP A  51
LEU A  49
GLN A  41
None
0.80A 3g4lA-3g6iA:
undetectable
3g4lA-3g6iA:
18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hjv MALONYL COA-ACYL
CARRIER PROTEIN
TRANSACYLASE


(Vibrio cholerae)
PF00698
(Acyl_transf_1)
3 ASP A  26
LEU A  27
GLN A  84
SO4  A 319 (-4.9A)
None
SO4  A 323 (-3.4A)
0.81A 3g4lA-3hjvA:
undetectable
3g4lA-3hjvA:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iy5 ANTIBODY FRAGMENT
IGG2A (LIGHT CHAIN)


(Mus musculus)
PF07686
(V-set)
3 ASP A  83
LEU A 105
GLN A   6
None
0.80A 3g4lA-3iy5A:
undetectable
3g4lA-3iy5A:
14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j1e CHAPERONIN BETA
SUBUNIT


(Acidianus
tengchongensis)
PF00118
(Cpn60_TCP1)
3 ASP A 157
LEU A 160
GLN A 499
None
0.59A 3g4lA-3j1eA:
undetectable
3g4lA-3j1eA:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jau HEAVY CHAIN OF FAB
FRAGMENT VARIABLE
REGION OF ANTIBODY
D5


(Mus musculus)
PF07686
(V-set)
3 ASP H  90
LEU H 114
GLN H   6
None
0.81A 3g4lA-3jauH:
undetectable
3g4lA-3jauH:
14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mil ISOAMYL
ACETATE-HYDROLYZING
ESTERASE


(Saccharomyces
cerevisiae)
PF13472
(Lipase_GDSL_2)
3 ASP A 125
LEU A 185
GLN A  29
None
0.83A 3g4lA-3milA:
undetectable
3g4lA-3milA:
18.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o57 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 392
LEU A 393
GLN A 443
ZN  A   1 (-2.6A)
None
ZG2  A 506 (-3.3A)
0.27A 3g4lA-3o57A:
51.6
3g4lA-3o57A:
80.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ohm 1-PHOSPHATIDYLINOSIT
OL-4,5-BISPHOSPHATE
PHOSPHODIESTERASE
BETA-3


(Homo sapiens)
PF00168
(C2)
PF00387
(PI-PLC-Y)
PF00388
(PI-PLC-X)
PF09279
(EF-hand_like)
3 ASP B 227
LEU B 231
GLN B 245
None
0.80A 3g4lA-3ohmB:
undetectable
3g4lA-3ohmB:
17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3omb EXTRACELLULAR
SOLUTE-BINDING
PROTEIN, FAMILY 1


(Bifidobacterium
longum)
PF01547
(SBP_bac_1)
3 ASP A 153
LEU A 421
GLN A  51
None
0.81A 3g4lA-3ombA:
undetectable
3g4lA-3ombA:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3one ADENOSYLHOMOCYSTEINA
SE


(Lupinus luteus)
PF00670
(AdoHcyase_NAD)
PF05221
(AdoHcyase)
3 ASP A 142
LEU A 145
GLN A 215
None
0.75A 3g4lA-3oneA:
undetectable
3g4lA-3oneA:
20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r5e TRANSALDOLASE

(Corynebacterium
glutamicum)
PF00923
(TAL_FSA)
3 ASP A 118
LEU A 121
GLN A 184
None
0.83A 3g4lA-3r5eA:
undetectable
3g4lA-3r5eA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rhg PUTATIVE
PHOPHOTRIESTERASE


(Proteus
mirabilis)
PF02126
(PTE)
3 ASP A 294
LEU A 257
GLN A  55
CAC  A 370 (-2.4A)
None
None
0.79A 3g4lA-3rhgA:
undetectable
3g4lA-3rhgA:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ry9 ANCESTRAL
GLUCOCORTICOID
RECEPTOR 1


(synthetic
construct)
PF00104
(Hormone_recep)
3 ASP A  60
LEU A  64
GLN A 230
None
0.80A 3g4lA-3ry9A:
undetectable
3g4lA-3ry9A:
19.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 318
LEU A 319
GLN A 369
ASP  A 318 (-0.5A)
LEU  A 319 ( 0.6A)
GLN  A 369 (-0.6A)
0.34A 3g4lA-3sl5A:
53.4
3g4lA-3sl5A:
98.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t8l ADENINE DEAMINASE 2

(Agrobacterium
fabrum)
PF01979
(Amidohydro_1)
PF13382
(Adenine_deam_C)
3 ASP A  15
LEU A  18
GLN A  30
None
0.77A 3g4lA-3t8lA:
undetectable
3g4lA-3t8lA:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tgw V-TYPE ATP SYNTHASE
BETA CHAIN


(Methanosarcina
mazei)
PF00006
(ATP-synt_ab)
PF02874
(ATP-synt_ab_N)
3 ASP A 279
LEU A 280
GLN A 299
None
0.66A 3g4lA-3tgwA:
undetectable
3g4lA-3tgwA:
22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tni CYCLIN-T1

(Homo sapiens)
PF00134
(Cyclin_N)
3 ASP B  32
LEU B  35
GLN B 190
None
0.73A 3g4lA-3tniB:
undetectable
3g4lA-3tniB:
21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u44 ATP-DEPENDENT
HELICASE/NUCLEASE
SUBUNIT A


(Bacillus
subtilis)
PF00580
(UvrD-helicase)
PF12705
(PDDEXK_1)
PF13361
(UvrD_C)
3 ASP A 298
LEU A 301
GLN A 895
None
0.64A 3g4lA-3u44A:
undetectable
3g4lA-3u44A:
15.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u7v BETA-GALACTOSIDASE

(Caulobacter
vibrioides)
PF02449
(Glyco_hydro_42)
3 ASP A 315
LEU A 316
GLN A 365
None
0.77A 3g4lA-3u7vA:
undetectable
3g4lA-3u7vA:
19.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uam CHITIN BINDING
DOMAIN


(Burkholderia
pseudomallei)
PF03067
(LPMO_10)
3 ASP A  39
LEU A  38
GLN A 207
None
0.75A 3g4lA-3uamA:
undetectable
3g4lA-3uamA:
17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ui7 CAMP AND
CAMP-INHIBITED CGMP
3',5'-CYCLIC
PHOSPHODIESTERASE
10A


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 674
LEU A 675
GLN A 726
ZN  A 772 (-2.4A)
C1L  A   1 (-4.3A)
C1L  A   1 (-2.9A)
0.41A 3g4lA-3ui7A:
38.0
3g4lA-3ui7A:
27.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4d7k SAM-DEPENDENT
METHYLTRANSFERASES


(Streptomyces
davaonensis)
PF00891
(Methyltransf_2)
3 ASP A  91
LEU A  92
GLN A 164
None
0.67A 3g4lA-4d7kA:
undetectable
3g4lA-4d7kA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dxy CYTOCHROME P450

(Novosphingobium
aromaticivorans)
PF00067
(p450)
3 ASP A 173
LEU A 177
GLN A 183
None
0.77A 3g4lA-4dxyA:
undetectable
3g4lA-4dxyA:
21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e2i LARGE T ANTIGEN

(Macaca mulatta
polyomavirus 1)
PF06431
(Polyoma_lg_T_C)
3 ASP A 283
LEU A 345
GLN A 519
None
0.75A 3g4lA-4e2iA:
undetectable
3g4lA-4e2iA:
23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f0j PROBABLE HYDROLYTIC
ENZYME


(Pseudomonas
aeruginosa)
PF00561
(Abhydrolase_1)
3 ASP A 243
LEU A 240
GLN A  48
None
0.56A 3g4lA-4f0jA:
undetectable
3g4lA-4f0jA:
23.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fkz UDP-N-ACETYLGLUCOSAM
INE 2-EPIMERASE


(Bacillus
subtilis)
PF02350
(Epimerase_2)
3 ASP A  47
LEU A  46
GLN A  68
None
None
UD1  A 401 (-3.9A)
0.76A 3g4lA-4fkzA:
undetectable
3g4lA-4fkzA:
24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gax AMORPHA-4,11-DIENE
SYNTHASE


(Artemisia annua)
PF01397
(Terpene_synth)
PF03936
(Terpene_synth_C)
3 ASP A  55
LEU A  54
GLN A  81
None
0.79A 3g4lA-4gaxA:
undetectable
3g4lA-4gaxA:
22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hl7 NICOTINATE
PHOSPHORIBOSYLTRANSF
ERASE


(Vibrio cholerae)
PF04095
(NAPRTase)
3 ASP A  56
LEU A  55
GLN A 115
None
0.77A 3g4lA-4hl7A:
undetectable
3g4lA-4hl7A:
23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4htz CGMP-DEPENDENT
3',5'-CYCLIC
PHOSPHODIESTERASE


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 808
LEU A 809
GLN A 859
ZN  A1001 (-2.5A)
None
None
0.45A 3g4lA-4htzA:
38.5
3g4lA-4htzA:
27.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4igm 2-AMINO-3-CARBOXYMUC
ONATE-6-SEMIALDEHYDE
DECARBOXYLASE


(Homo sapiens)
PF04909
(Amidohydro_2)
3 ASP A  99
LEU A  96
GLN A 142
None
0.76A 3g4lA-4igmA:
undetectable
3g4lA-4igmA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4irn PROLYL-ACP
DEHYDROGENASE


([Oscillatoria]
sp. PCC 6506)
PF00441
(Acyl-CoA_dh_1)
PF02770
(Acyl-CoA_dh_M)
PF02771
(Acyl-CoA_dh_N)
3 ASP A  32
LEU A  28
GLN A 262
None
0.81A 3g4lA-4irnA:
undetectable
3g4lA-4irnA:
18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4itx CYSTATHIONINE
BETA-LYASE METC


(Escherichia
coli)
PF01053
(Cys_Met_Meta_PP)
3 ASP A 386
LEU A 387
GLN A 282
None
0.79A 3g4lA-4itxA:
undetectable
3g4lA-4itxA:
22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mfi SN-GLYCEROL-3-PHOSPH
ATE ABC TRANSPORTER
SUBSTRATE-BINDING
PROTEIN USPB


(Mycobacterium
tuberculosis)
PF13416
(SBP_bac_8)
3 ASP A 204
LEU A 205
GLN A 381
None
0.75A 3g4lA-4mfiA:
undetectable
3g4lA-4mfiA:
23.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n30 PROTEIN DISULFIDE
ISOMERASE


(Pseudomonas
aeruginosa)
PF13462
(Thioredoxin_4)
3 ASP A 145
LEU A 144
GLN A 115
None
0.73A 3g4lA-4n30A:
undetectable
3g4lA-4n30A:
18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n3y RAB GTPASE-BINDING
EFFECTOR PROTEIN 1


(Homo sapiens)
PF09311
(Rab5-bind)
3 ASP B 577
LEU B 581
GLN B 587
None
0.81A 3g4lA-4n3yB:
undetectable
3g4lA-4n3yB:
14.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nfd PAIRED
IMMUNOGLOBULIN-LIKE
TYPE 2 RECEPTOR BETA


(Homo sapiens)
PF07686
(V-set)
3 ASP A  89
LEU A 117
GLN A   7
None
0.83A 3g4lA-4nfdA:
undetectable
3g4lA-4nfdA:
14.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o6d NS1

(West Nile virus)
PF00948
(Flavi_NS1)
3 ASP B  24
LEU B 198
GLN B  66
None
0.77A 3g4lA-4o6dB:
undetectable
3g4lA-4o6dB:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p7w L-PROLINE
CIS-4-HYDROXYLASE


(Mesorhizobium
japonicum)
PF05118
(Asp_Arg_Hydrox)
PF05373
(Pro_3_hydrox_C)
3 ASP A  19
LEU A  23
GLN A  52
None
0.78A 3g4lA-4p7wA:
undetectable
3g4lA-4p7wA:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pj3 INTRON-BINDING
PROTEIN AQUARIUS


(Homo sapiens)
PF13086
(AAA_11)
PF13087
(AAA_12)
PF16399
(Aquarius_N)
3 ASP A1269
LEU A1299
GLN A1136
None
0.69A 3g4lA-4pj3A:
undetectable
3g4lA-4pj3A:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4r9x COPPER HOMEOSTASIS
PROTEIN CUTC


(Bacillus
anthracis)
PF03932
(CutC)
3 ASP A 106
LEU A 107
GLN A  81
CA  A 303 (-2.9A)
None
None
0.81A 3g4lA-4r9xA:
undetectable
3g4lA-4r9xA:
22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ru5 TAILSPIKE GP27

(Pseudomonas
phage phi297)
no annotation 3 ASP A 613
LEU A 620
GLN A 554
None
0.76A 3g4lA-4ru5A:
undetectable
3g4lA-4ru5A:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4win GMP SYNTHETASE

(Plasmodium
falciparum)
PF00117
(GATase)
3 ASP A  37
LEU A  12
GLN A  98
None
0.77A 3g4lA-4winA:
undetectable
3g4lA-4winA:
20.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wzi CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
PF00233
(PDEase_I)
3 ASP A 564
LEU A 565
GLN A 615
ZN  A 801 (-2.5A)
None
None
0.17A 3g4lA-4wziA:
52.2
3g4lA-4wziA:
47.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xmm NUCLEOPORIN NUP145

(Saccharomyces
cerevisiae)
PF12110
(Nup96)
3 ASP B 188
LEU B 191
GLN B 449
None
0.71A 3g4lA-4xmmB:
undetectable
3g4lA-4xmmB:
20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y0i 4-AMINOBUTYRATE
AMINOTRANSFERASE,
MITOCHONDRIAL


(Sus scrofa)
PF00202
(Aminotran_3)
3 ASP A 393
LEU A 394
GLN A 400
None
0.70A 3g4lA-4y0iA:
undetectable
3g4lA-4y0iA:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yj1 UNCHARACTERIZED
PROTEIN


(Trypanosoma
brucei)
PF09818
(ABC_ATPase)
3 ASP A 444
LEU A 445
GLN A 404
None
0.76A 3g4lA-4yj1A:
undetectable
3g4lA-4yj1A:
18.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yzz TRAP TRANSPORTER
SOLUTE BINDING
PROTEIN


(Bordetella
bronchiseptica)
PF03480
(DctP)
3 ASP A 113
LEU A 110
GLN A 197
None
0.56A 3g4lA-4yzzA:
undetectable
3g4lA-4yzzA:
20.67